In summary, routine assessment of renal function using the 2021 CKD-EPI equation(incorporating creatinine and cystatin C) [25, 26] is critical for ASCVD riskmanagement, and allows early identification of high-risk CKD populations. Here, CST3 is linked to chronic kidney disease.